John J. McCabe
2017
In 2017, John J. McCabe earned a total compensation of $501.8K as Former Chief Financial Officer at Eleven Biotherapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $156,165 |
| Salary | $259,424 |
| Other | $11,161 |
| Total | $501,750 |
McCabe received $259.4K in salary, accounting for 52% of the total pay in 2017.
McCabe also received $75K in bonus, $156.2K in option awards and $11.2K in other compensation.
Rankings
In 2017, John J. McCabe's compensation ranked 11,859th out of 14,666 executives tracked by ExecPay. In other words, McCabe earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,859 out of 14,666 | 19th |
Division Manufacturing | 4,670 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,704 out of 2,075 | 18th |
Industry group Drugs | 1,413 out of 1,731 | 18th |
Industry Pharmaceutical Preparations | 1,105 out of 1,333 | 17th |
Source: SEC filing on April 30, 2018.
McCabe's colleagues
We found three more compensation records of executives who worked with John J. McCabe at Eleven Biotherapeutics in 2017.